Tobacco News and Research

RSS

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML).

1 Sep 2017

FDA grants clearance for first 2D digital mammography system with patient-assisted compression

Today, the U.S. Food and Drug Administration cleared the first 2D digital mammography system that allows patients to increase or decrease the amount of compression applied to their own breast before the mammogram x-ray is taken.

1 Sep 2017

Consistent e-cigarette use does help smokers quit, researchers say

Frequent e-cigarette use does help smokers quit - a finding that Georgetown Lombardi Comprehensive Cancer Center researchers say supports the use of e-cigarettes as a cessation aid for those trying to quit cigarette smoking. But, they note, an examination of a recent national survey uncovers important clues about who's successful at quitting and why.

31 Aug 2017

FDA approves first cell-based gene therapy for use in the United States

The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.

30 Aug 2017

FDA approves new antibacterial treatment for adults with cUTI

The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.

30 Aug 2017

Researchers use biochemical validation to verify claims of smoking cessation

According to a recent study led by The University of Kansas Cancer Center researchers, a high proportion of smokers enrolled in bedside tobacco cessation programs who said they had quit were misreporting their smoking status.

29 Aug 2017

FDA grants accelerated approval to new treatment for children with Chagas disease

The U.S. Food and Drug Administration today granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United States for the treatment of Chagas disease.

29 Aug 2017

Researchers provide approaches to optimize cardiovascular risk reduction for patients with SAMS

Statins are highly effective for preventing heart attacks by reducing low-density lipoprotein or "bad" cholesterol.

29 Aug 2017

FDA issues warning letter to US Stem Cell Clinic for significant deviations

The U.S. Food and Drug Administration today posted a warning letter issued to US Stem Cell Clinic of Sunrise, Florida, and its Chief Scientific Officer Kristin Comella for marketing stem cell products without FDA approval and for significant deviations from current good manufacturing practice requirements, including some that could impact the sterility of their products, putting patients at risk.

28 Aug 2017

Lung experts test nicotine patches as potential treatment for sarcoidosis

Doctors believe there is some good to be found in nicotine, the highly addictive drug in tobacco products. Lung experts at The Ohio State University Wexner Medical Center are testing whether nicotine can help people with a chronic inflammatory lung disease called sarcoidosis.

28 Aug 2017

Reducing nicotine content in cigarettes may help decrease addiction, research suggests

The FDA is right - when it comes to disease culprits, cigarette smoking tops the list. While recognized as the number-one cause of preventable disease and death, it's an incredibly tough habit to break due to the addictiveness of nicotine.

23 Aug 2017

Routine dental checkups offer opportunity to observe changes in patient’s health

Dentists and hygienists see more than just teeth. They can see early signs of certain diseases - often before patients know they have them.

22 Aug 2017

Plant virus-based system can be used to deliver anti-cancer drugs

An article published in Experimental Biology and Medicine (Volume 242, Issue 14, August 2017) reports that a plant virus-based system can be used to deliver anti-cancer drugs.

21 Aug 2017

Peer influence on adolescent smoking found to be more powerful in collectivist cultures

The way things stand now, tobacco use will kill one billion people in the 21st century. In the United States, 90 percent of smokers pick up the habit by age 18, making adolescence a critical time for smoking-prevention efforts.

21 Aug 2017

Lowering nicotine levels, use of e-cigarettes and raising cigarette prices associated with smoking cessation

The United States Food and Drug Administration (FDA) have waged a war against smoking and now new steps are in place to help quitters go ahead and stop smoking.

20 Aug 2017

Older smokers more likely to quit with increase in cigarette prices, study finds

Older smokers are usually more set in their ways, but a dollar increase in cigarette prices makes them 20 percent more likely to quit, a new Drexel University study found.

18 Aug 2017

FDA provides panel of human plasma samples to evaluate serological tests for detecting Zika infection

As an additional measure in the fight against Zika virus, today the U.S. Food and Drug Administration announced that it has made available a panel of human plasma samples to aid in the regulatory evaluation of serological tests to detect recent Zika virus infection.

18 Aug 2017

UH gets $3.3 million funding from Cancer Prevention and Research Institute of Texas

The University of Houston has received $3.3 million from the Cancer Prevention and Research Institute of Texas.

18 Aug 2017

Study identifies link between e-cigarette and tobacco use in school children

A new study, published in the journal Tobacco Control has found a link showing that school children who use e-cigarettes are more likely to try tobacco within a year.

18 Aug 2017

$FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL$

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

17 Aug 2017

Tobacco News and Research

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

FDA grants clearance for first 2D digital mammography system with patient-assisted compression

Consistent e-cigarette use does help smokers quit, researchers say

FDA approves first cell-based gene therapy for use in the United States

FDA approves new antibacterial treatment for adults with cUTI

Researchers use biochemical validation to verify claims of smoking cessation

FDA grants accelerated approval to new treatment for children with Chagas disease

Researchers provide approaches to optimize cardiovascular risk reduction for patients with SAMS

FDA issues warning letter to US Stem Cell Clinic for significant deviations

Lung experts test nicotine patches as potential treatment for sarcoidosis

Reducing nicotine content in cigarettes may help decrease addiction, research suggests

Routine dental checkups offer opportunity to observe changes in patient’s health

Plant virus-based system can be used to deliver anti-cancer drugs

Peer influence on adolescent smoking found to be more powerful in collectivist cultures

Lowering nicotine levels, use of e-cigarettes and raising cigarette prices associated with smoking cessation

Older smokers more likely to quit with increase in cigarette prices, study finds

FDA provides panel of human plasma samples to evaluate serological tests for detecting Zika infection

UH gets $3.3 million funding from Cancer Prevention and Research Institute of Texas

Study identifies link between e-cigarette and tobacco use in school children

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News